NIH-funded research NIH-funded research

High throughput DNA sequencing for advanced genomic research

Official title: Illumina NovaSeq X Plus High Throughput DNA Sequencer for Emory University

Funded at Emory University · NIH-11102640 · Data updated 2026-11-12

This study is all about getting a new, high-tech DNA sequencing machine to help researchers at Emory University learn more about the genes involved in neurodegenerative diseases, which could lead to better treatments for patients like you in the future.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionEmory University
NIH-funded
Lab location1 site (Atlanta, United States)
Project startMay 15, 2025
Project endMay 14, 2026
Funding year2025
Award (this year)$1,083,750
NIH project number1S10OD038274-01
Project IDNIH-11102640 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research include individuals affected by neurodegenerative conditions or those involved in related biomedical research.

Less likely to help

Patients with conditions unrelated to neurodegeneration or those not engaged in research activities may not receive direct benefits from this research.

What this research studies

This research aims to enhance genomic analysis capabilities at Emory University by acquiring a state-of-the-art Illumina NovaSeq X Plus Sequencing System. The system will facilitate deep sequencing of DNA, allowing researchers to explore genome-wide DNA methylation profiles and identify differentially expressed genes, particularly in the context of neurodegenerative conditions. By providing in-house access to advanced sequencing technology, the project will support a diverse range of biomedical research initiatives and improve the efficiency and cost-effectiveness of genomic studies. Patients may benefit indirectly through advancements in understanding and treating neurodegenerative diseases.

Why it matters

Potential benefit: If successful, this research could lead to significant advancements in the understanding and treatment of neurodegenerative diseases.

How similar studies have gone: Previous research utilizing advanced sequencing technologies has shown significant success in enhancing our understanding of genetic factors in various diseases, indicating a promising potential for this approach.

Where this research is happening

  • Emory University
    Atlanta, United States
    Active

Researchers

  • Principal investigator: Bosinger, Steven Edward — Emory University
  • Study coordinator: Bosinger, Steven Edward

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.